Salix Pharmaceuticals Ltd (SLXP) Tops Q3 EPS by 25c; Boosts Views
Tweet Send to a Friend
Salix Pharmaceuticals Ltd (NASDAQ: SLXP) reported Q3 EPS of $0.95, $0.25 better than the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
